• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-24调节黄曲霉毒素B1相关的肝细胞癌预后和肿瘤发生。

MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis.

作者信息

Liu Yi-Xiao, Long Xi-Dai, Xi Zhi-Feng, Ma Yun, Huang Xiao-Ying, Yao Jin-Guang, Wang Chao, Xing Tian-Yu, Xia Qiang

机构信息

Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Dongfang Road, No. 1630, Shanghai 200127, China.

Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Dongfang Road, No. 1630, Shanghai 200127, China ; Department of Pathology, Youjiang Medical College for Nationalities, Baise 533000, China.

出版信息

Biomed Res Int. 2014;2014:482926. doi: 10.1155/2014/482926. Epub 2014 Apr 8.

DOI:10.1155/2014/482926
PMID:24800232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3997078/
Abstract

MicroRNA-24 (miR-24) may be involved in neoplastic process; however, the role of this microRNA in the hepatocellular carcinoma (HCC) related to aflatoxin B1 (AFB1) has not been well elaborated. Here, we tested miR-24 expression in 207 pathology-diagnosed HCC cases from high AFB1 exposure areas and HCC cells. We found that miR-24 was upregulated in HCC tumor tissues relative to adjacent noncancerous tissue samples, and that the high expression of miR-24 was significantly correlated with larger tumor size, higher microvessel density, and tumor dedifferentiation. Additionally, this microRNA overexpression modified the recurrence-free survival (relative hazard ratio [HR], 4.75; 95% confidence interval [CI], 2.66-8.47) and overall survival (HR = 3.58, 95% CI = 2.34-5.46) of HCC patients. Furthermore, we observed some evidence of joint effects between miR-24 and AFB1 exposure on HCC prognosis. Functionally, miR-24 overexpression progressed tumor cells proliferation, inhibited cell apoptosis, and developed the formation of AFB1-DNA adducts. These results indicate for the first time that miR-24 may modify AFB1-related HCC prognosis and tumorigenesis.

摘要

微小RNA-24(miR-24)可能参与肿瘤形成过程;然而,这种微小RNA在与黄曲霉毒素B1(AFB1)相关的肝细胞癌(HCC)中的作用尚未得到充分阐述。在此,我们检测了来自高AFB1暴露地区的207例经病理诊断的HCC病例以及HCC细胞中miR-24的表达。我们发现,相对于相邻的非癌组织样本,miR-24在HCC肿瘤组织中上调,并且miR-24的高表达与更大的肿瘤大小、更高的微血管密度和肿瘤去分化显著相关。此外,这种微小RNA的过表达改变了HCC患者的无复发生存率(相对风险比[HR],4.75;95%置信区间[CI],2.66 - 8.47)和总生存率(HR = 3.58,95% CI = 2.34 - 5.46)。此外,我们观察到一些miR-24与AFB1暴露对HCC预后联合作用的证据。在功能上,miR-24过表达促进肿瘤细胞增殖,抑制细胞凋亡,并促进AFB1 - DNA加合物的形成。这些结果首次表明,miR-24可能改变与AFB1相关的HCC预后和肿瘤发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834a/3997078/88ca49b5ccd9/BMRI2014-482926.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834a/3997078/1ac3489826c8/BMRI2014-482926.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834a/3997078/7d29513de31d/BMRI2014-482926.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834a/3997078/8f7f456e5b12/BMRI2014-482926.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834a/3997078/88ca49b5ccd9/BMRI2014-482926.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834a/3997078/1ac3489826c8/BMRI2014-482926.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834a/3997078/7d29513de31d/BMRI2014-482926.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834a/3997078/8f7f456e5b12/BMRI2014-482926.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/834a/3997078/88ca49b5ccd9/BMRI2014-482926.006.jpg

相似文献

1
MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis.微小RNA-24调节黄曲霉毒素B1相关的肝细胞癌预后和肿瘤发生。
Biomed Res Int. 2014;2014:482926. doi: 10.1155/2014/482926. Epub 2014 Apr 8.
2
Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma.前体微小RNA多态性与黄曲霉毒素B1相关的肝细胞癌
Mol Carcinog. 2016 Jun;55(6):1060-72. doi: 10.1002/mc.22350. Epub 2015 Jul 8.
3
MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis.miRNA-429 调节肝癌的预后和肿瘤发生。
Gastroenterol Res Pract. 2013;2013:804128. doi: 10.1155/2013/804128. Epub 2013 Sep 24.
4
Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population.广西人群中着色性干皮病互补组 C 密码子 939 多态性与黄曲霉毒素 B1 相关的肝细胞癌。
Hepatology. 2010 Oct;52(4):1301-9. doi: 10.1002/hep.23807.
5
Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma.X 射线修复交叉互补基因 4 编码区多态性与黄曲霉毒素 B1 相关的肝细胞癌。
Hepatology. 2013 Jul;58(1):171-81. doi: 10.1002/hep.26311. Epub 2013 May 14.
6
Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.DNA修复基因多态性与黄曲霉毒素B1在肝细胞癌风险中的相互作用。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6231-44. eCollection 2014.
7
Mutational spectra of aflatoxin B in vivo establish biomarkers of exposure for human hepatocellular carcinoma.黄曲霉毒素 B 在体内的突变谱确立了人肝细胞癌暴露的生物标志物。
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):E3101-E3109. doi: 10.1073/pnas.1700759114. Epub 2017 Mar 28.
8
Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.尽管在日本南部地区,人们接触黄曲霉毒素 B1 的水平较低,但肝癌患者的肝内黄曲霉毒素 B1-DNA 加合物和 TP53 突变仍然存在。
Liver Int. 2011 Oct;31(9):1366-72. doi: 10.1111/j.1478-3231.2011.02572.x. Epub 2011 Jun 28.
9
Distinct response of the hepatic transcriptome to Aflatoxin B1 induced hepatocellular carcinogenesis and resistance in rats.黄曲霉毒素 B1 诱导的大鼠肝癌发生和耐药中肝转录组的独特反应。
Sci Rep. 2016 Aug 22;6:31898. doi: 10.1038/srep31898.
10
The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.中国广西人群中XRCC3密码子241多态性与黄曲霉毒素B1相关性肝细胞癌
Ann Epidemiol. 2008 Jul;18(7):572-8. doi: 10.1016/j.annepidem.2008.03.003. Epub 2008 May 27.

引用本文的文献

1
Mycotoxin-Caused Intestinal Toxicity: Underlying Molecular Mechanisms and Further Directions.霉菌毒素引起的肠道毒性:潜在分子机制及未来方向
Toxics. 2025 Jul 26;13(8):625. doi: 10.3390/toxics13080625.
2
The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO.基于来自基因表达综合数据库(GEO)的转录组分析的人类肝细胞癌中的miRNA-mRNA调控网络
Cancer Rep (Hoboken). 2025 Jan;8(1):e70098. doi: 10.1002/cnr2.70098.
3
Menin in Cancer.Menin 在癌症中的作用。

本文引用的文献

1
MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis.miRNA-429 调节肝癌的预后和肿瘤发生。
Gastroenterol Res Pract. 2013;2013:804128. doi: 10.1155/2013/804128. Epub 2013 Sep 24.
2
Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.肌球蛋白调节蛋白通过 miR-24/-29a 和血小板衍生生长因子受体-β 调节血管对损伤的反应。
Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2355-65. doi: 10.1161/ATVBAHA.112.301000. Epub 2013 Jul 3.
3
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer.
Genes (Basel). 2024 Sep 21;15(9):1231. doi: 10.3390/genes15091231.
4
Tissue inhibitor of metalloproteinase-3 expression affects clinicopathological features and prognosis of aflatoxin B1-related hepatocellular carcinoma.金属蛋白酶组织抑制剂-3表达影响黄曲霉毒素B1相关肝细胞癌的临床病理特征及预后。
World J Hepatol. 2024 Aug 27;16(8):1131-1144. doi: 10.4254/wjh.v16.i8.1131.
5
MicroRNAs: exploring their role in farm animal disease and mycotoxin challenges.微小RNA:探索它们在农场动物疾病和霉菌毒素挑战中的作用。
Front Vet Sci. 2024 May 13;11:1372961. doi: 10.3389/fvets.2024.1372961. eCollection 2024.
6
Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis.黄曲霉毒素B1-DNA加合物可改变术后辅助性经动脉化疗栓塞的效果,改善肝细胞癌的预后。
Explor Target Antitumor Ther. 2023;4(4):780-792. doi: 10.37349/etat.2023.00167. Epub 2023 Aug 31.
7
Research progress in toxicological effects and mechanism of aflatoxin B toxin.黄曲霉毒素 B1 毒素的毒理学效应及作用机制研究进展。
PeerJ. 2022 Aug 4;10:e13850. doi: 10.7717/peerj.13850. eCollection 2022.
8
MicroRNA regulates the toxicological mechanism of four mycotoxins in vivo and in vitro.微小RNA在体内和体外调节四种霉菌毒素的毒理学机制。
J Anim Sci Biotechnol. 2022 Feb 24;13(1):37. doi: 10.1186/s40104-021-00653-4.
9
Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.miR-24/24-1*/24-2*表达在癌症及其他人类疾病中的多样作用。
Am J Transl Res. 2022 Jan 15;14(1):20-54. eCollection 2022.
10
Prognostic significance of microRNA miR-24 in cancers: a meta-analysis.miR-24 在癌症中的预后意义:一项荟萃分析。
Bioengineered. 2021 Dec;12(1):450-460. doi: 10.1080/21655979.2021.1875662.
循环 miR-22、miR-24 和 miR-34a 作为新型预测生物标志物用于晚期非小细胞肺癌培美曲塞为基础的化疗。
J Cell Physiol. 2014 Jan;229(1):97-9. doi: 10.1002/jcp.24422.
4
Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.DNA 修复基因 XRCC4 和 XRCC5 的遗传多态性与黄曲霉毒素 B1 相关的肝细胞癌。
Epidemiology. 2013 Sep;24(5):671-81. doi: 10.1097/EDE.0b013e31829d2744.
5
MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a.微小 RNA miR-24 通过靶向细胞周期蛋白依赖性激酶抑制剂 p27Kip1 和 p16INK4a 促进细胞增殖。
J Cell Physiol. 2013 Oct;228(10):2015-23. doi: 10.1002/jcp.24368.
6
MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.MicroRNA miR-24 通过靶向 PTPN9 和 PTPRF 促进 EGF 信号来增强肿瘤侵袭和转移。
J Cell Sci. 2013 Mar 15;126(Pt 6):1440-53. doi: 10.1242/jcs.118299. Epub 2013 Feb 15.
7
Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma.X 射线修复交叉互补基因 4 编码区多态性与黄曲霉毒素 B1 相关的肝细胞癌。
Hepatology. 2013 Jul;58(1):171-81. doi: 10.1002/hep.26311. Epub 2013 May 14.
8
MiR-24 promotes the survival of hematopoietic cells.miR-24 促进造血细胞的存活。
PLoS One. 2013;8(1):e55406. doi: 10.1371/journal.pone.0055406. Epub 2013 Jan 30.
9
MicroRNA-feedback loop as a key modulator of liver tumorigenesis and inflammation.微小 RNA 反馈环作为肝脏肿瘤发生和炎症的关键调节因子。
World J Gastroenterol. 2013 Jan 28;19(4):440-4. doi: 10.3748/wjg.v19.i4.440.
10
Modeling microRNA-transcription factor networks in cancer.癌症中的 microRNA-转录因子网络建模。
Adv Exp Med Biol. 2013;774:149-67. doi: 10.1007/978-94-007-5590-1_9.